POLYMED.BOPOLYMED.BOBSE

Revenue (LTM)

$16.7B

+21.4% YoY

Net Income (LTM)

$3.4B

+31.1% YoY

Free Cash Flow

$-906M

Revenue CAGR (5Y)

+19.4%

—Marginsstable

FCF($0.9B)

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	7,865	9,231↑17.4%	11,152↑20.8%	13,758↑23.4%	16,698↑21.4%
Gross Profit	5,229	5,724↑9.5%	7,062↑23.4%	8,891↑25.9%	11,110↑25.0%
Operating Income	3,650	3,865↑5.9%	4,808↑24.4%	6,180↑28.6%	7,759↑25.5%
Net Income	1,359	1,465↑7.8%	1,793↑22.4%	2,583↑44.1%	3,386↑31.1%
EBITDA	2,125	2,118↓0.3%	2,677↑26.4%	3,577↑33.6%	4,521↑26.4%
EPS Diluted	15.24	15.27↑0.2%	18.67↑22.3%	26.90↑44.1%	34.11↑26.8%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	50	78↑56.6%	71↓9.0%	121↑70.7%	1,513↑1155.6%
Total Current Assets	7,058	7,834↑11.0%	8,070↑3.0%	8,416↑4.3%	19,170↑127.8%
Total Assets	12,237	13,768↑12.5%	15,772↑14.6%	18,587↑17.8%	31,925↑71.8%
Total Current Liabilities	1,714	2,267↑32.3%	2,933↑29.4%	3,512↑19.8%	3,702↑5.4%
Total Liabilities	2,582	2,894↑12.1%	3,356↑16.0%	3,886↑15.8%	4,268↑9.8%
Total Equity	9,656	10,875↑12.6%	12,416↑14.2%	14,701↑18.4%	27,657↑88.1%
Total Debt	1,374	1,267↓7.8%	1,490↑17.6%	1,742↑16.9%	1,802↑3.5%
Net Debt	1,325	1,190↓10.2%	1,420↑19.3%	1,621↑14.2%	289↓82.2%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	1,187	1,235↑4.0%	1,908↑54.5%	2,661↑39.4%	2,404↓9.6%
Capital Expenditure	-951	-1,556↓63.5%	-2,393↓53.8%	-2,770↓15.8%	-3,310↓19.5%
Free Cash Flow	236	-321↓236.0%	-484↓50.9%	-109↑77.4%	-906↓728.7%
Stock-Based Comp	6	9↑43.8%	19↑107.0%	0	12
Net Change in Cash	1	28↑2783.5%	-7↓124.8%	50↑818.1%	-34↓167.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance